PEG.CO
Price:
$0.103
Market Cap:
$126.44M
Pharma Equity Group A/S invests in companies with a primary focus on life sciences. It focuses on early investment in life science companies that develop technologies and therapies that enhances human health and quality of life. The company is based in Hørsholm, Denmark.
Industry
Biotechnology
IPO Date
2023-05-16
Stock Exchange
CPH
Ticker
PEG.CO
According to Pharma Equity Group A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 144.19M. This represents a change of -32.84% compared to the average of 214.69M of the last 4 quarters.
The mean historical Enterprise Value of Pharma Equity Group A/S over the last ten years is 95.80M. The current 144.19M Enterprise Value has changed 14.95% with respect to the historical average. Over the past ten years (40 quarters), PEG.CO's Enterprise Value was at its highest in in the June 2023 quarter at 606.19M. The Enterprise Value was at its lowest in in the September 2022 quarter at 0.
Average
95.80M
Median
34.85M
Minimum
9.21M
Maximum
490.54M
Discovering the peaks and valleys of Pharma Equity Group A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.75%
Maximum Annual Enterprise Value = 490.54M
Minimum Annual Increase = -72.91%
Minimum Annual Enterprise Value = 9.21M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 212.49M | -56.68% |
| 2023 | 490.54M | 1.19% |
| 2022 | 37.95M | -9.01% |
| 2021 | 41.71M | 80.67% |
| 2020 | 23.09M | -72.91% |
| 2019 | 85.21M | 657.44% |
| 2018 | 11.25M | 22.11% |
| 2017 | 9.21M | -37.78% |
| 2016 | 14.81M | -53.35% |
| 2015 | 31.75M | 3.75% |
The current Enterprise Value of Pharma Equity Group A/S (PEG.CO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
246.99M
5-year avg
161.16M
10-year avg
95.80M
Pharma Equity Group A/S’s Enterprise Value is less than Scandinavian Medical Solutions A/S (154.07M), greater than ViroGates A/S (112.68M), greater than Stenocare A/S (60.15M), greater than Monsenso A/S (11.37M), greater than Brain+ A/S (6.76M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 154.07M | $105.49M | |
| 112.68M | $119.51M | |
| 60.15M | $62.19M | |
| 11.37M | $12.75M | |
| 6.76M | $11.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Equity Group A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharma Equity Group A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharma Equity Group A/S's Enterprise Value?
What is the highest Enterprise Value for Pharma Equity Group A/S (PEG.CO)?
What is the 3-year average Enterprise Value for Pharma Equity Group A/S (PEG.CO)?
What is the 5-year average Enterprise Value for Pharma Equity Group A/S (PEG.CO)?
How does the current Enterprise Value for Pharma Equity Group A/S (PEG.CO) compare to its historical average?